FDA Clears Sirolimus (Rapamune) for Rare Lung Disease

Sirolimus is the first drug approved in the US to treat lymphangioleiomyomatosis (LAM), a very rare, progressive lung disease that primarily affects women of childbearing age.
FDA Approvals …read more